Transfer of Risperidone and 9-Hydroxyrisperidone into Human Milk

Abstract

Maternal risperidone therapy is unlikely to be a significant hazard for the breast-fed infant in the short term. Nevertheless, decisions on whether a woman may breast-feed should be made as an individual risk-benefit analysis.